Protein C Rewrites Its Circle of Molecular Partners as Children Grow

Deep inside every drop of blood, a molecular peacekeeper called protein C patrols the circulatory system, quietly deciding when clotting should stop and when damaged tissue deserves protection. For decades, clinicians have known that the amount of protein C circulating in plasma rises steadily from birth into adulthood, and that its structure and functional activity shift along the way. What has remained stubbornly invisible is the company it keeps. A new study published in Clinical Proteomics by Simon Collett, Chantal Attard, Paul Monagle and colleagues at the University of Melbourne, the Murdoch Children’s Research Institute and collaborating Melbourne institutions has now mapped, for the first time, how the web of proteins that physically associate with protein C transforms across human development, from neonates through to adults. The results reveal a haemostatic system that is not simply an immature version of the adult one, but a dynamically rewired network whose architecture changes with every stage of growing up.

Protein C occupies a uniquely important position in the biology of blood. Synthesised in the liver as an inactive zymogen, it circulates until the thrombin-thrombomodulin complex on endothelial cells cleaves it into activated protein C, or APC. Once activated, APC performs a remarkable triple duty: it proteolytically inactivates the clotting factors Va and VIIIa, damping down coagulation; it modulates inflammation through signalling pathways such as protease-activated receptor 1; and it exerts cytoprotective effects that help endothelial barriers survive injury. Because these functions depend on precisely choreographed interactions with other plasma and cell-surface proteins, the activity of protein C cannot be inferred from its concentration alone. Its structural conformation, its binding partners and the surrounding protein context all shape what it actually does in the bloodstream. This distinction matters enormously in paediatrics, where reference ranges for clotting proteins differ dramatically from adult norms and where children are neither small adults nor scaled-down versions of them.

The Melbourne team set out to interrogate this hidden dimension using co-immunoprecipitation, a technique that exploits the specificity of an antibody to fish a target protein, and everything physically bound to it, out of a complex biological mixture. Working with plasma samples pooled into age groups spanning neonates to adults, the researchers used an anti-protein C antibody to capture protein C along with its interacting partners. The captured proteins were then digested and identified by liquid chromatography coupled to tandem mass spectrometry, or LC-MS/MS, the workhorse technology of modern proteomics. By comparing which proteins were enriched in the protein C pull-downs relative to controls, and which were depleted, the team could build an age-resolved picture of the protein C interactome. Multivariate tools including principal component analysis and partial least squares discriminant analysis were then applied to test whether the co-precipitating proteomes segregated cleanly by age, while functional enrichment analysis asked what biological pathways the changing partners represented.

The answer was emphatic. The protein C co-precipitating proteome changed substantially across development, and the differences were most pronounced in the youngest cohorts. In neonates and infants, the enrichment of protein C itself in the pull-downs was the most striking feature, hinting that the molecular environment surrounding protein C in early life differs fundamentally from that of later childhood and adulthood. The number of identifiable interaction partners also fluctuated in unexpected ways: the largest complement of protein C associates appeared in the 11 to 16 year-old group, while the smallest was found in children aged 6 to 10. That the peak of interaction complexity occurs in adolescence, rather than adulthood, was among the more surprising patterns to emerge from the data, suggesting that the adolescent haemostatic system may be assembling a particularly rich set of protein C-centred complexes as it transitions toward the mature adult state.

What kinds of proteins were keeping company with protein C? The functional analyses pointed to age-specific networks spanning several biological domains. Beyond the expected haemostatic partners, the co-precipitating proteins included platelet-related proteins, components of the complement cascade, and immune-related proteins. This breadth is biologically provocative. It implies that protein C does not operate in a closed coagulation circuit but sits at the intersection of clotting, innate immunity and inflammatory signalling, and that the relative weight of these connections shifts with age. In early development, when the immune system is still calibrating its responses and the vascular system is maturing, protein C may be drawn into different protein communities than in adulthood, when the networks have settled into their mature configuration. The plasma proteome, in other words, is not a fixed backdrop but a shifting stage on which protein C plays a changing role.

Yet the study also uncovered a deeper layer of conservation beneath the surface variability. When the researchers performed pathway analysis on the age-specific interactomes, they found significant cross-over in the biological pathways represented across age ranges, even though the individual proteins identified as participating in those pathways differed. The same functional themes, coagulation regulation, platelet biology, complement activation and immune modulation, recurred from neonates to adults, but with different molecular actors filling the roles at each stage. This is a conceptually important finding: it suggests that the developing haemostatic system maintains its core functions by swapping components rather than by inventing new ones. The orchestra keeps playing the same symphony, but the instrumentation changes with age, and protein C sits at the centre of the score.

The technical achievement underlying these conclusions should not be understated. Co-immunoprecipitation from plasma is notoriously challenging, because abundant proteins such as albumin and immunoglobulins can swamp the signal, and transient or weak interactions may not survive the capture process. The team’s workflow, incorporating filter-assisted sample preparation and rigorous false discovery rate control in the mass spectrometric identifications, was designed to separate genuine co-precipitating partners from background. Pooling samples within age groups provided the statistical power needed to detect developmental trends, though it also means the study captures population-level patterns rather than individual variation. The raw data have been deposited in the ProteomeXchange repository under identifier PXD077907, allowing other researchers to reanalyse the interactomes and test the team’s interpretations independently, a transparency measure that strengthens confidence in the findings.

The clinical implications reach into one of the persistent puzzles of paediatric medicine: why children’s clotting systems behave so differently from adults’, and why therapies calibrated on adult data can misfire in young patients. Developmental haemostasis, the recognition that the coagulation system matures in a coordinated but non-uniform fashion, has reshaped how paediatric haematologists interpret clotting tests and dose anticoagulants. This study adds a new dimension to that framework. If protein C’s interaction partners change with age, then the anticoagulant, anti-inflammatory and cytoprotective functions of the protein C pathway may likewise vary across development, even when measured concentrations appear adequate. For conditions in which protein C plays a documented role, from sepsis-associated coagulopathy to thrombotic risk in children, an age-aware interactome could eventually inform more precise diagnostic thresholds and treatment strategies. The work was funded through an Investigator Initiated Research Agreement with Takeda Pharmaceutical, which the authors state had no role in the design, analysis or decision to publish.

There remain, of course, important caveats and open questions. Co-immunoprecipitation identifies association, not necessarily direct binding, and some detected partners may reflect indirect membership of larger complexes. Pooled samples smooth over individual differences, and the functional consequences of most of the observed interactions remain to be tested experimentally. Whether the adolescent peak in interaction partners reflects a genuine biological programme or a transient compositional state of plasma will require longitudinal follow-up. Nevertheless, the study opens a genuinely new window onto developmental haemostasis. It demonstrates that the protein C interactome is a moving target, remodelling itself across childhood and adolescence, and that the functional identity of a well-characterised anticoagulant protein cannot be fully understood without accounting for the company it keeps. As proteomic techniques grow more sensitive, the shifting social network of protein C may prove to be a key to understanding why the blood of a newborn, a ten-year-old and an adult are three different molecular worlds.

Subject of Research: Age-dependent changes in the protein-protein interaction partners of protein C in human plasma across development

Article Title: Age-dependent changes in protein interaction partners of protein C

Article References: Age-dependent changes in protein interaction partners of protein C. (n.d.). https://doi.org/10.1186/s12014-026-09638-9

Image Credits: AI Generated

DOI: 10.1186/s12014-026-09638-9

Keywords: protein C, co-immunoprecipitation, LC-MS/MS, developmental haemostasis, interactome, protein-protein interactions, plasma proteome, paediatric haematology, coagulation, complement, mass spectrometry, proteomics